For research use only. Not for therapeutic Use.
Ko-3290 is an antagonist of β-adrenoceptor, with cardioselectivity and antilipolytic effects in animals.
| Catalog Number | I013582 |
| CAS Number | 79848-61-6 |
| Molecular Formula | C₁₉H₂₅N₃O₃ |
| Purity | ≥95% |
| Target | Adrenergic Receptor |
| Solubility | DMSO |
| IUPAC Name | N-[3-cyano-4-[2-hydroxy-3-(2-methylbut-3-yn-2-ylamino)propoxy]phenyl]-2-methylpropanamide |
| InChI | InChI=1S/C19H25N3O3/c1-6-19(4,5)21-11-16(23)12-25-17-8-7-15(9-14(17)10-20)22-18(24)13(2)3/h1,7-9,13,16,21,23H,11-12H2,2-5H3,(H,22,24) |
| InChIKey | OPEGAEBRVGIBAS-UHFFFAOYSA-N |
| SMILES | CC(C)C(=O)NC1=CC(=C(C=C1)OCC(CNC(C)(C)C#C)O)C#N |
| Reference | [1]. T.H.PRINGLE, et al. The assessment of the-3-adrenoceptor blocking activity and cardioselectivity of Koe3290 innormal subjects. British Journal of Clinical Pharmacology (1987), 24(5), 581-9 |
